Clinical Trial

Evaluation of IL 12B Genetic Polymorphism (rs3213094)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.
Trial Details
NCT Number NCT07128472
Lead Sponsor South Valley University
Conditions Psoriasis
Enrollment 40 participants
Start Date 2025-08-01
Primary Completion 2026-01-20 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-19